EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Air travel and cystic fibrosis: An algorithm to assess the risk of In-Flight Hypoxemia

A Akerø, E Edvardsen, P L Finstad, B Skrede, M Østerhaug, S Backman, A Edvardsen, O H Skjønsberg

Journal of Cystic Fibrosis · 2025

DOI: 10.1016/j.jcf.2025.05.004 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von A Akerø und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Air Travel, Algorithms, Cystic Fibrosis, Hypoxia. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Centre for rare disorders, Oslo University Hospital, Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Air travel may cause significant hypoxemia in patients with cystic fibrosis (CF). A pre-flight algorithm has previously been validated for patients with chronic obstructive pulmonary disease (COPD). No such tools are available for CF patients. The aim of this study was to evaluate if the pre-flight algorithm for COPD patients can be used by CF patients. METHODS: In this prospective cross-sectional study, oxygen saturation at sea level (SpO2 SL) and during exercise (SpO2 6MWT) were used to evaluate whether CF patients a) are fit for flight without further assessment, b) require in-flight supplemental oxygen, or c) need further evaluation with hypoxia-altitude simulation test (HAST). HAST was used as reference method, and SpO2 HAST ≤85 % was the criterion for recommending in-flight supplemental oxygen. RESULTS: 79 CF patients (41 men), age 38.0 ± 13.4 years, with FEV1 of 71±23 % of predicted underwent HAST (SpO2 HAST 89.2 ± 4.0 %). Categories for SpO2 SL were >95 % (N = 53), 92-95 % (N = 25), and 95 % combined with SpO2 6MWT ≥84 % can travel by air without further assessment. Supplemental oxygen is recommended if SpO2 SL is 92-95 % combined with SpO2 6MWT

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Air TravelAlgorithmsCystic FibrosisHypoxiaAdultFemaleHumansMaleMiddle AgedCross-Sectional StudiesOxygen SaturationProspective StudiesPulmonary Disease, Chronic ObstructiveRisk Assessment

Stichwörter der Autor:innen

Air travelCystic fibrosisHypoxaemiaPre-flight algorithm

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway; Norwegian Resource Centre for Cystic Fibrosis, Oslo, Norway.
  • Norwegian Resource Centre for Cystic Fibrosis, Oslo, Norway.
  • Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.
  • Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. Electronic address: o.h.skjonsberg@medisin.uio.no.

Förderung

  • Centre for rare disorders, Oslo University Hospital, Norway

Zitieren

APA

Akerø, A., Edvardsen, E., Finstad, P. L., Skrede, B., Østerhaug, M., Backman, S., Edvardsen, A., & Skjønsberg, O. H. (2025). Air travel and cystic fibrosis: An algorithm to assess the risk of In-Flight Hypoxemia. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.05.004

Vancouver

Akerø A, Edvardsen E, Finstad PL, Skrede B, Østerhaug M, Backman S, et al. Air travel and cystic fibrosis: An algorithm to assess the risk of In-Flight Hypoxemia. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.05.004

BibTeX
@article{Aker2025,
  author = {Akerø, A and Edvardsen, E and Finstad, P L and Skrede, B and Østerhaug, M and Backman, S and Edvardsen, A and Skjønsberg, O H},
  title = {Air travel and cystic fibrosis: An algorithm to assess the risk of In-Flight Hypoxemia},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  doi = {10.1016/j.jcf.2025.05.004}
}
Kostenlos starten →